Neogen Corp. engages in the provision of development, manufacture, and marketing of food and animal safety products. The company is headquartered in Lansing, Michigan and currently employs 2,974 full-time employees. The firm has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. Its segments include Food Safety and Animal Safety. The Food Safety segment is primarily engaged in the development, production and marketing of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation. The Animal Safety segment is primarily engaged in the development, production and marketing of products dedicated to animal safety, including a complete line of consumable products marketed to veterinarians and animal health product distributors. This segment also provides genomic identification and related interpretive bioinformatic services.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
05/31/2025
05/31/2024
05/31/2023
05/31/2022
05/31/2021
Revenue
880
894
924
822
527
468
Revenue Growth (YoY)
-4%
-3%
12%
56%
13%
12%
Cost of Revenue
475
473
460
416
284
253
Gross Profit
404
421
463
406
243
215
Selling, General & Admin
344
401
367
282
167
124
Research & Development
20
21
22
26
17
16
Operating Expenses
434
423
389
308
184
140
Other Non Operating Income (Expenses)
0
0
0
-1
0
0
Pretax Income
-617
-1,133
-14
-22
60
75
Income Tax Expense
-14
-41
-4
0
11
14
Net Income
-602
-1,092
-9
-22
48
60
Net Income Growth
26%
12,033%
-59%
-146%
-20%
2%
Shares Outstanding (Diluted)
217.4
216.89
216.48
188.9
108
107.1
Shares Change (YoY)
0%
0%
15%
75%
1%
1%
EPS (Diluted)
-2.77
-5.03
-0.04
-0.12
0.45
0.57
EPS Growth
26%
11,474%
-64%
-127%
-21%
2%
Free Cash Flow
-18
-46
-76
-24
43
54
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
45.9%
47.09%
50.1%
49.39%
46.11%
45.94%
Operating Margin
-3.29%
-0.11%
8%
11.8%
11%
15.81%
Profit Margin
-68.4%
-122.14%
-0.97%
-2.67%
9.1%
12.82%
Free Cash Flow Margin
-2.04%
-5.14%
-8.22%
-2.91%
8.15%
11.53%
EBITDA
88
118
190
185
81
95
EBITDA Margin
10%
13.19%
20.56%
22.5%
15.37%
20.29%
D&A For EBITDA
117
119
116
88
23
21
EBIT
-29
-1
74
97
58
74
EBIT Margin
-3.29%
-0.11%
8%
11.8%
11%
15.81%
Effective Tax Rate
2.26%
3.61%
28.57%
0%
18.33%
18.66%
Follow-Up Questions
What are Neogen Corp's key financial statements?
According to the latest financial statement (Form-10K), Neogen Corp has a total asset of $3,443, Net loss of $-1,092
What are the key financial ratios for NEOG?
Neogen Corp's Current ratio is 2.5, has a Net margin is -122.14, sales per share of $4.12.
How is Neogen Corp's revenue broken down by segment or geography?
Neogen Corp largest revenue segment is Natural Toxins & Allergens, at a revenue of 77,058,000 in the most earnings release.For geography, Domestic is the primary market for Neogen Corp, at a revenue of 445,935,000.
Is Neogen Corp profitable?
no, according to the latest financial statements, Neogen Corp has a net loss of $-1,092
Does Neogen Corp have any liabilities?
yes, Neogen Corp has liability of 1,372
How many outstanding shares for Neogen Corp?
Neogen Corp has a total outstanding shares of 216.61